Eric T Schwartz, MD | |
230 Beiser Blvd, Ste 100, Dover, DE 19904-7791 | |
(302) 730-0840 | |
(302) 730-3006 |
Full Name | Eric T Schwartz |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 36 Years |
Location | 230 Beiser Blvd, Dover, Delaware |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811991565 | NPI | - | NPPES |
0000762501 | Medicaid | DE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | C1-0004912 (Delaware) | Primary |
Entity Name | Delaware Orthopaedics And Sports Medicine |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063452928 PECOS PAC ID: 7214926310 Enrollment ID: O20040512000153 |
News Archive
While African American men are more likely to die from cardiovascular disease, they paradoxically have fewer cases of coronary obstruction than clinically similar white men, according to a new national study led by a Medical College of Wisconsin researcher.
A new research paper by scientists at Janssen Vaccines & Prevention BV, in the Netherlands and published on the preprint server bioRxiv* is based on the assumption that an effective vaccine against these infections will induce neutralizing antibodies and an immune response favoring Th1 immunity.
Response Genetics, Inc. announced today that it has entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share. The signing of the purchase agreement occurred on Friday, March 5, 2010. We expect the final closing of the shares will occur on Monday, March 8, 2010.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that top-line data from its previously announced open-label, active-comparator study of its lead product candidate, the Sufentanil NanoTab PCA System, will be featured in poster presentations to be held at the 66th annual New York State Society of Anesthesiologists PostGraduate Assembly meeting in New York City to be held December 14-18, 2012.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Eric T Schwartz, MD 230 Beiser Blvd, Ste 100, Dover, DE 19904-7791 Ph: (302) 730-0840 | Eric T Schwartz, MD 230 Beiser Blvd, Ste 100, Dover, DE 19904-7791 Ph: (302) 730-0840 |
News Archive
While African American men are more likely to die from cardiovascular disease, they paradoxically have fewer cases of coronary obstruction than clinically similar white men, according to a new national study led by a Medical College of Wisconsin researcher.
A new research paper by scientists at Janssen Vaccines & Prevention BV, in the Netherlands and published on the preprint server bioRxiv* is based on the assumption that an effective vaccine against these infections will induce neutralizing antibodies and an immune response favoring Th1 immunity.
Response Genetics, Inc. announced today that it has entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share. The signing of the purchase agreement occurred on Friday, March 5, 2010. We expect the final closing of the shares will occur on Monday, March 8, 2010.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that top-line data from its previously announced open-label, active-comparator study of its lead product candidate, the Sufentanil NanoTab PCA System, will be featured in poster presentations to be held at the 66th annual New York State Society of Anesthesiologists PostGraduate Assembly meeting in New York City to be held December 14-18, 2012.
› Verified 7 days ago
Dr. J Hamilton Easter Jr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 720 S Queen St, Dover, DE 19904 Phone: 302-735-8705 Fax: 302-735-8703 | |
John Robert Burger, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 655 S Bay Rd Ste 1f, Dover, DE 19901 Phone: 302-730-4366 Fax: 302-730-0231 | |
Jonathan L Kates, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 540 S Governors Ave, Suite 201, Dover, DE 19904 Phone: 302-730-4366 Fax: 302-730-0231 | |
Stephen L Malone, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 260 Beiser Blvd, Suite 101, Dover, DE 19904 Phone: 302-734-9700 Fax: 302-734-9702 | |
Steven E Tooze, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 285 Beiser Blvd Ste 201, Dover, DE 19904 Phone: 302-731-2888 Fax: 302-731-7049 | |
Dr. Andrew Joseph Gambone, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 655 S Bay Rd Ste 1f, Dover, DE 19901 Phone: 302-730-4366 Fax: 302-730-0231 | |
Lawrence Piccioni, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 260 Beiser Blvd, Suite 101, Dover, DE 19904 Phone: 302-730-8060 Fax: 302-730-8063 |